Skip to main content
Top
Gepubliceerd in: Journal of Behavioral Medicine 5/2017

21-04-2017

Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result

Auteurs: Amanda T. Wiggins, Edward J. Pavlik, Michael A. Andrykowski

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 5/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

While participation in cancer screening can facilitate early detection and improved prognosis, all screening tests yield some proportion of abnormal test results which are later determined benign. These false positive (FP) results can negatively impact affective, cognitive, and behavioral outcomes. Women participating in an ovarian cancer (OC) screening program receiving an abnormal screening test result (n = 375) were matched with women receiving normal results (n = 375). Both groups completed a baseline and 1- and 4-month follow-up assessments. FP test results were clearly associated with increased cancer-specific distress and increased perceptions of OC risk with more limited evidence for increased perceived positive consequences of screening and increased intentions to participate in future OC screening. FP OC screening test results negatively impact both affective and cognitive outcomes which may serve to reduce motivation to participate in future routine screening. The development and testing of brief, timely interventions to minimize this negative impact is warranted.
Literatuur
go back to reference Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179–211.CrossRef Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179–211.CrossRef
go back to reference American Cancer Society. (2015). Cancer facts and figures. Atlanta: American Cancer Society. American Cancer Society. (2015). Cancer facts and figures. Atlanta: American Cancer Society.
go back to reference American Cancer Society. (2016). Cancer facts and figures. Atlanta: American Cancer Society. American Cancer Society. (2016). Cancer facts and figures. Atlanta: American Cancer Society.
go back to reference Andersen, M. R., Drescher, C. W., Zheng, Y., Bowen, D. J., Wilson, S., Young, A., et al. (2007). Changes in cancer worry associated with participation in ovarian cancer screening. Psycho-Oncology, 16, 814–820.CrossRefPubMed Andersen, M. R., Drescher, C. W., Zheng, Y., Bowen, D. J., Wilson, S., Young, A., et al. (2007). Changes in cancer worry associated with participation in ovarian cancer screening. Psycho-Oncology, 16, 814–820.CrossRefPubMed
go back to reference Andrykowski, M. A., Boerner, L. M., Salsman, J. M., & Pavlik, E. (2004). Psychological response to test results in an ovarian cancer screening program: A prospective, longitudinal study. Health Psychology, 23, 622–630.CrossRefPubMed Andrykowski, M. A., Boerner, L. M., Salsman, J. M., & Pavlik, E. (2004). Psychological response to test results in an ovarian cancer screening program: A prospective, longitudinal study. Health Psychology, 23, 622–630.CrossRefPubMed
go back to reference Andrykowski, M. A., Carpenter, J. S., Studts, J. L., Cordova, M. J., Cunningham, L. L., Beacham, A., et al. (2002). Psychological impact of benign breast biopsy: A longitudinal, comparative study. Health Psychology, 21, 485–494.CrossRefPubMed Andrykowski, M. A., Carpenter, J. S., Studts, J. L., Cordova, M. J., Cunningham, L. L., Beacham, A., et al. (2002). Psychological impact of benign breast biopsy: A longitudinal, comparative study. Health Psychology, 21, 485–494.CrossRefPubMed
go back to reference Andrykowski, M. A., Zhang, M., Pavlik, E. J., & Kryscio, R. J. (2007). Factors associated with return for routine annual screening in an ovarian cancer screening program. Gynecologic Oncology, 104, 695–701.CrossRefPubMed Andrykowski, M. A., Zhang, M., Pavlik, E. J., & Kryscio, R. J. (2007). Factors associated with return for routine annual screening in an ovarian cancer screening program. Gynecologic Oncology, 104, 695–701.CrossRefPubMed
go back to reference Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001). Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20, 20–32.CrossRefPubMed Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001). Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20, 20–32.CrossRefPubMed
go back to reference Barrett, J., Jenkins, V., Farewell, V., Menon, U., Jacobs, I., Kilkerr, J., et al. (2014). Psychological morbidity associated with ovarian cancer screening: Results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS). British Journal of Obstetrics and Gynecology, 121, 1071–1079.CrossRef Barrett, J., Jenkins, V., Farewell, V., Menon, U., Jacobs, I., Kilkerr, J., et al. (2014). Psychological morbidity associated with ovarian cancer screening: Results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS). British Journal of Obstetrics and Gynecology, 121, 1071–1079.CrossRef
go back to reference Brain, K. E., Lifford, K. J., Fraser, L., Rosenthal, A. N., Rogers, M. T., Lancastle, D., et al. (2012). Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm. Gynecologic Oncology, 127, 556–563.CrossRefPubMed Brain, K. E., Lifford, K. J., Fraser, L., Rosenthal, A. N., Rogers, M. T., Lancastle, D., et al. (2012). Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm. Gynecologic Oncology, 127, 556–563.CrossRefPubMed
go back to reference Brewer, N. T., Salz, T., & Lillie, S. E. (2007). Systematic review: The long-term effects of false-positive mammograms. Annals of Internal Medicine, 146, 502–510.CrossRefPubMed Brewer, N. T., Salz, T., & Lillie, S. E. (2007). Systematic review: The long-term effects of false-positive mammograms. Annals of Internal Medicine, 146, 502–510.CrossRefPubMed
go back to reference Cockburn, J., De Luise, T., Hurley, S., & Clover, K. (1992). Development and validation of the PCQ: A questionnaire to measure the psychological consequences of screening mammography. Social Science and Medicine, 34, 1129–1134.CrossRefPubMed Cockburn, J., De Luise, T., Hurley, S., & Clover, K. (1992). Development and validation of the PCQ: A questionnaire to measure the psychological consequences of screening mammography. Social Science and Medicine, 34, 1129–1134.CrossRefPubMed
go back to reference DePriest, P. D., & DeSimone, C. P. (2003). Ultrasound screening for early detection of ovarian cancer. Journal of Clinical Oncology, 21, 194s–199s.CrossRefPubMed DePriest, P. D., & DeSimone, C. P. (2003). Ultrasound screening for early detection of ovarian cancer. Journal of Clinical Oncology, 21, 194s–199s.CrossRefPubMed
go back to reference Floyd, A., Steffens, R. F., Pavlik, E., & Andrykowski, M. A. (2011). Receipt of a false positive test result during routine screening for ovarian cancer: A teachable moment?. Journal of Clinical Psychology in Medical Settings, 18, 70–77.CrossRefPubMedPubMedCentral Floyd, A., Steffens, R. F., Pavlik, E., & Andrykowski, M. A. (2011). Receipt of a false positive test result during routine screening for ovarian cancer: A teachable moment?. Journal of Clinical Psychology in Medical Settings, 18, 70–77.CrossRefPubMedPubMedCentral
go back to reference Hays, R. D., & Wooley, J. M. (2000). The concept of clinically meaningful differences in health-related quality of life research: How meaningful is it? Pharmacoeconomics, 18, 419–423.CrossRefPubMed Hays, R. D., & Wooley, J. M. (2000). The concept of clinically meaningful differences in health-related quality of life research: How meaningful is it? Pharmacoeconomics, 18, 419–423.CrossRefPubMed
go back to reference Helgeson, V. S., Reynolds, K. A., & Tomich, P. L. (2006). A meta-analytic review of benefit finding and growth. Journal of Consulting and Clinical Psychology, 74, 797–816.CrossRefPubMed Helgeson, V. S., Reynolds, K. A., & Tomich, P. L. (2006). A meta-analytic review of benefit finding and growth. Journal of Consulting and Clinical Psychology, 74, 797–816.CrossRefPubMed
go back to reference Horowitz, M. (1982). Stress response symptoms and their treatment. In L. Goldberger & S. Breznitz (Eds.), Handbook of stress: Theoretical and clinical aspects (pp. 711–732). New York: Free Press. Horowitz, M. (1982). Stress response symptoms and their treatment. In L. Goldberger & S. Breznitz (Eds.), Handbook of stress: Theoretical and clinical aspects (pp. 711–732). New York: Free Press.
go back to reference Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209–218.CrossRefPubMed Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209–218.CrossRefPubMed
go back to reference Jenkins, V., for and on behalf of UKCTOS Trialists, Fallowfield, L., Langridge, C., Barrett, J., Ryan, A., Jacobs, I., Kilkerr, J., Menon, U., & Farewell, V. (2015). Psychological factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening. International Journal of Gyncegological Cancer, 25, 1519–1525. Jenkins, V., for and on behalf of UKCTOS Trialists, Fallowfield, L., Langridge, C., Barrett, J., Ryan, A., Jacobs, I., Kilkerr, J., Menon, U., & Farewell, V. (2015). Psychological factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening. International Journal of Gyncegological Cancer, 25, 1519–1525.
go back to reference Kauff, N. D., Hurley, K. E., Hensley, M. L., Robson, M. E., Lev, G., Goldfrank, D., et al. (2005). Ovarian carcinoma screening in women at intermediate risk: Impact on quality of life and need for invasive follow-up. Cancer, 104, 314–320.CrossRefPubMed Kauff, N. D., Hurley, K. E., Hensley, M. L., Robson, M. E., Lev, G., Goldfrank, D., et al. (2005). Ovarian carcinoma screening in women at intermediate risk: Impact on quality of life and need for invasive follow-up. Cancer, 104, 314–320.CrossRefPubMed
go back to reference Lifford, K. J., Fraser, L., Rosenthal, A. N., Rogers, M. T., Lancastle, D., Phelps, C., et al. (2012). Withdrawal from familial ovarian screening for surgery: Findings from a psychological evaluation study (Psy FOCS). Gynecologic Oncology, 124, 158–163.CrossRefPubMed Lifford, K. J., Fraser, L., Rosenthal, A. N., Rogers, M. T., Lancastle, D., Phelps, C., et al. (2012). Withdrawal from familial ovarian screening for surgery: Findings from a psychological evaluation study (Psy FOCS). Gynecologic Oncology, 124, 158–163.CrossRefPubMed
go back to reference Lin, K., Lipsitz, R., Miller, T., & Janakiraman, S. (2008). Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the U.S. Preventive services task force. Annals of Internal Medicine, 149, 192–199.CrossRefPubMed Lin, K., Lipsitz, R., Miller, T., & Janakiraman, S. (2008). Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the U.S. Preventive services task force. Annals of Internal Medicine, 149, 192–199.CrossRefPubMed
go back to reference McGovern, P. M., Gross, C. R., Krueger, R. A., Engelhard, D. A., Cordes, J. E., & Church, T. R. (2004). False-positive cancer screens and health-related quality of life. Cancer Nursing, 27, 347–352.CrossRefPubMed McGovern, P. M., Gross, C. R., Krueger, R. A., Engelhard, D. A., Cordes, J. E., & Church, T. R. (2004). False-positive cancer screens and health-related quality of life. Cancer Nursing, 27, 347–352.CrossRefPubMed
go back to reference Menon, U., Griffin, M., & Gentry-Maharaj, A. (2014). Ovarian cancer screening—current status, future directions. Gynecologic Oncology, 132, 490–495.CrossRefPubMedPubMedCentral Menon, U., Griffin, M., & Gentry-Maharaj, A. (2014). Ovarian cancer screening—current status, future directions. Gynecologic Oncology, 132, 490–495.CrossRefPubMedPubMedCentral
go back to reference Moyer, V.A., & U.S. Preventive Services Task Force. (2012). Screening for ovarian cancer: U.S. preventive services task force reaffirmation recommendation statement. Annals of Internal Medicine, 157, 900–904.CrossRef Moyer, V.A., & U.S. Preventive Services Task Force. (2012). Screening for ovarian cancer: U.S. preventive services task force reaffirmation recommendation statement. Annals of Internal Medicine, 157, 900–904.CrossRef
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.PubMed Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.PubMed
go back to reference Pavlik, E. J., Ueland, F. R., Miller, R. V. V., Ubellacker, J. M., DeSomone, C. P., Hoff, J., et al. (2013). Frequency and disposition of ovarian abnormalities followed with serial transvaginal sonography. Obstetrics and Gynecology, 122, 210–217.CrossRefPubMed Pavlik, E. J., Ueland, F. R., Miller, R. V. V., Ubellacker, J. M., DeSomone, C. P., Hoff, J., et al. (2013). Frequency and disposition of ovarian abnormalities followed with serial transvaginal sonography. Obstetrics and Gynecology, 122, 210–217.CrossRefPubMed
go back to reference Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRef Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRef
go back to reference Reade, C. J., Riva, J. J., Busse, J. W., Goldsmith, C. H., & Elit, L. (2013). Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis. Gynecologic Oncology, 130, 674–681.CrossRefPubMed Reade, C. J., Riva, J. J., Busse, J. W., Goldsmith, C. H., & Elit, L. (2013). Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis. Gynecologic Oncology, 130, 674–681.CrossRefPubMed
go back to reference Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994). Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. Journal of Personality and Social Psychology, 67, 1063–1078.CrossRefPubMed Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994). Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. Journal of Personality and Social Psychology, 67, 1063–1078.CrossRefPubMed
go back to reference Schorge, J. O., Modesitt, S. C., Coleman, R. L., Cohn, D. E., Kauff, N. D., Duska, L. R., et al. (2010). SGO white paper on ovarian cancer: Etiology, screening and surveillance. Gynecologic Oncology, 119, 7–17.CrossRefPubMed Schorge, J. O., Modesitt, S. C., Coleman, R. L., Cohn, D. E., Kauff, N. D., Duska, L. R., et al. (2010). SGO white paper on ovarian cancer: Etiology, screening and surveillance. Gynecologic Oncology, 119, 7–17.CrossRefPubMed
go back to reference Schwartz, L. M., Woloshin, S., Fowler, F. J., Jr., & Welch, H. G. (2004). Enthusiasm for cancer screening in the United States. Journal of the American Medical Association, 291, 71–78.CrossRefPubMed Schwartz, L. M., Woloshin, S., Fowler, F. J., Jr., & Welch, H. G. (2004). Enthusiasm for cancer screening in the United States. Journal of the American Medical Association, 291, 71–78.CrossRefPubMed
go back to reference Slatore, C. G., Sullivan, D. R., Pappas, M., & Humphrey, L. L. (2014). Patient-centered outcomes among lung cancer screening recipients with computed tomography: A systematic review. Journal of Thoracic Oncology, 9, 927–934.CrossRefPubMed Slatore, C. G., Sullivan, D. R., Pappas, M., & Humphrey, L. L. (2014). Patient-centered outcomes among lung cancer screening recipients with computed tomography: A systematic review. Journal of Thoracic Oncology, 9, 927–934.CrossRefPubMed
go back to reference Stanton, A. L. (2010). Positive consequences of the experience of cancer: Perception of growth and meaning. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, et al. (Eds.), Psycho-oncology (2nd ed., pp. 547–550). New York: Oxford University Press.CrossRef Stanton, A. L. (2010). Positive consequences of the experience of cancer: Perception of growth and meaning. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, et al. (Eds.), Psycho-oncology (2nd ed., pp. 547–550). New York: Oxford University Press.CrossRef
go back to reference Stanton, A. L., Bower, J. E., & Low, C. A. (2006). Posttraumatic growth after cancer. In L. G. Calhoun & R. G. Tedeschi (Eds.), Handbook of posttraumatic growth: Research and practice (pp. 138–175). Mahwah, NJ: Erlbaum. Stanton, A. L., Bower, J. E., & Low, C. A. (2006). Posttraumatic growth after cancer. In L. G. Calhoun & R. G. Tedeschi (Eds.), Handbook of posttraumatic growth: Research and practice (pp. 138–175). Mahwah, NJ: Erlbaum.
go back to reference Steptoe, A. (1989). An abbreviated version of the Miller Behavioral Style Scale. British Journal of Clinical Psychology, 28(Pt 2), 183–184.CrossRefPubMed Steptoe, A. (1989). An abbreviated version of the Miller Behavioral Style Scale. British Journal of Clinical Psychology, 28(Pt 2), 183–184.CrossRefPubMed
go back to reference Taylor, K. L., Shleby, R., Gelmann, E., & McGuire, C. (2004). Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Journal of the National Cancer Institute, 96, 1083–1094.CrossRefPubMed Taylor, K. L., Shleby, R., Gelmann, E., & McGuire, C. (2004). Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Journal of the National Cancer Institute, 96, 1083–1094.CrossRefPubMed
go back to reference Tedeschi, R. G., & Calhoun, L. G. (1995). Trauma and transformation: Growing in the aftermath of significant suffering. Newbury Park, CA: Sage Publications.CrossRef Tedeschi, R. G., & Calhoun, L. G. (1995). Trauma and transformation: Growing in the aftermath of significant suffering. Newbury Park, CA: Sage Publications.CrossRef
go back to reference Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic growth: Conceptual foundations and empirical evidence. Psychological Inquiry, 15, 1–18.CrossRef Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic growth: Conceptual foundations and empirical evidence. Psychological Inquiry, 15, 1–18.CrossRef
go back to reference van Nagell, J. R., & Pavlik, E. J. (2012). Ovarian cancer screening. Clinics in Obstetrics and Gynecology, 55, 43–51.CrossRef van Nagell, J. R., & Pavlik, E. J. (2012). Ovarian cancer screening. Clinics in Obstetrics and Gynecology, 55, 43–51.CrossRef
go back to reference Wardle, J., Collins, W., Pernet, A. L., Whitehead, M. I., Bourne, T. H., & Campbell, S. (1993). Psychological impact of screening for familial ovarian cancer. Journal of the National Cancer Institute, 85, 653–657.CrossRefPubMed Wardle, J., Collins, W., Pernet, A. L., Whitehead, M. I., Bourne, T. H., & Campbell, S. (1993). Psychological impact of screening for familial ovarian cancer. Journal of the National Cancer Institute, 85, 653–657.CrossRefPubMed
go back to reference Wardle, J., Pernet, A., Collins, W., & Bourne, T. (1994). False positive results in ovarian cancer screening: One year follow-up of psychological status. Psychology and Health, 10, 33–40.CrossRef Wardle, J., Pernet, A., Collins, W., & Bourne, T. (1994). False positive results in ovarian cancer screening: One year follow-up of psychological status. Psychology and Health, 10, 33–40.CrossRef
go back to reference Wardle, J., & Pope, R. (1992). The psychological costs of screening for cancer. Journal of Psychosomatic Research, 36, 609–624.CrossRefPubMed Wardle, J., & Pope, R. (1992). The psychological costs of screening for cancer. Journal of Psychosomatic Research, 36, 609–624.CrossRefPubMed
go back to reference Wardle, J., Robb, K., Verson, S., & Waller, J. (2015). Screening for prevention and early diagnosis of cancer. American Psychologist, 70, 119–133.CrossRefPubMed Wardle, J., Robb, K., Verson, S., & Waller, J. (2015). Screening for prevention and early diagnosis of cancer. American Psychologist, 70, 119–133.CrossRefPubMed
go back to reference Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.CrossRefPubMed Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.CrossRefPubMed
Metagegevens
Titel
Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result
Auteurs
Amanda T. Wiggins
Edward J. Pavlik
Michael A. Andrykowski
Publicatiedatum
21-04-2017
Uitgeverij
Springer US
Gepubliceerd in
Journal of Behavioral Medicine / Uitgave 5/2017
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-017-9851-1

Andere artikelen Uitgave 5/2017

Journal of Behavioral Medicine 5/2017 Naar de uitgave